BioCatalystWatch
FBLGWorkspace / FBLG / OverviewCompany library
FibroBiologics, Inc. logo

FibroBiologics, Inc.

FibroBiologics, Inc. (FBLG)

Website

Price
Market cap
Next catalystFebruary 2027, subject to revised-protocol approval, trial progress and the stated six-week patient-treatment thresholdCYWC628 — Australian Phase 1/2 diabetic-foot-ulcer trial · Phase 1/2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

CYPS317

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

CYWC628

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

CYMS101

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CYPS317

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

CYWC628

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

CYMS101

PreINDP1P3FilingApproved
Upcoming / outlook

Other pipelines

CYWC628

CybroCell™

CybroCell™

History / paused

CYMS101

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

FBLG PR & News

PR & News

FBLG SEC archive